GM23396
iPSC from Fibroblast
Description:
APPARENTLY HEALTHY FETAL TISSUE
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Apparently healthy iPSCs Apparently Healthy Collection |
Protocols |
Protocol PDF |
Biopsy Source
|
Skin
|
Cell Type
|
Stem cell
|
Cell Subtype
|
Induced pluripotent stem cell
|
Transformant
|
Reprogrammed (Retroviral)
|
Sample Source
|
iPSC from Fibroblast
|
Race
|
Black/African American
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Karyotypic analysis and Case history
|
ISCN
|
46,XX
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
Induced Pluripotent Stem Cell |
The frozen cell line submitted to the Repository was recovered and expanded. The expanded line was evaluated for viability surface antigen expression and alkaline phosphatase activity. Pluripotency was assessed via embryoid body (EB) formation and PluriTest. Steady-state mRNA expression patterns of undifferentiated iPSC and EBs were determined via real-time PCR. Characterization data are included in the Certificate of Analysis. |
|
Remarks |
iPS line from skin fibroblast culture GM06111; 46,XX; 6% of cells show random chromosome loss. Researchers purchasing hiPSCs from the NIGMS Repository are responsible for any limited use label licenses (LULLs) applicable to the cell line purchased. The applicable LULL to this line is WARF. |
Split Ratio |
1:6 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Ham's F12 Medium/Dulbecco Modified Eagles Medium, 1:1 mixture with 2mM L-glutamine or equivalent |
Serum |
20% Knock-out Serum Replacement Not inactivated |
Substrate |
Gelatin + Feeder Layer |
Supplement |
Basic Fibroblast Growth Factor 100ng/ml |
|
|